- Home
- SHOT vs PULM Comparison
SHOT vs PULM Comparison
Compare SHOT & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- PULM
- Stock Information
- Founded
- SHOT 2018
- PULM 2003
- Country
- SHOT United States
- PULM United States
- Employees
- SHOT N/A
- PULM N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- PULM Health Care
- Exchange
- SHOT Nasdaq
- PULM Nasdaq
- Market Cap
- SHOT 33.4M
- PULM 30.9M
- IPO Year
- SHOT 2020
- PULM N/A
- Fundamental
- Price
- SHOT $0.45
- PULM $6.31
- Analyst Decision
- SHOT
- PULM
- Analyst Count
- SHOT 0
- PULM 0
- Target Price
- SHOT N/A
- PULM N/A
- AVG Volume (30 Days)
- SHOT 737.5K
- PULM 19.7K
- Earning Date
- SHOT 05-14-2025
- PULM 05-09-2025
- Dividend Yield
- SHOT N/A
- PULM N/A
- EPS Growth
- SHOT N/A
- PULM N/A
- EPS
- SHOT N/A
- PULM N/A
- Revenue
- SHOT $701,967.00
- PULM $7,806,000.00
- Revenue This Year
- SHOT N/A
- PULM N/A
- Revenue Next Year
- SHOT N/A
- PULM $134.88
- P/E Ratio
- SHOT N/A
- PULM N/A
- Revenue Growth
- SHOT 246.36
- PULM 6.96
- 52 Week Low
- SHOT $0.34
- PULM $1.72
- 52 Week High
- SHOT $2.14
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SHOT 49.11
- PULM 49.72
- Support Level
- SHOT $0.36
- PULM $5.31
- Resistance Level
- SHOT $0.53
- PULM $6.07
- Average True Range (ATR)
- SHOT 0.05
- PULM 0.50
- MACD
- SHOT 0.01
- PULM 0.03
- Stochastic Oscillator
- SHOT 57.59
- PULM 63.59
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.